Pfizer Sales Force Stays: Changes Include “Modest” Cuts, No Lay-Offs
Pfizer is not planning dramatic cuts in its sales force over the next three years - and the withdrawal of the COX-2 inhibitor Bextra is not likely to affect that plan
Pfizer is not planning dramatic cuts in its sales force over the next three years - and the withdrawal of the COX-2 inhibitor Bextra is not likely to affect that plan